Private equity firm Revival Healthcare Capital reported capital commitments of $500 million for its RVLHC II fund earlier this week.
The latest fund for the Austin-based firm will pursue strategic growth opportunities in companies that advance innovative medical device technologies into global markets. Officials said they will invest directly in companies and will have a structural option or right to acquire the company in the future.
“Consolidation has made it increasingly difficult for medtech leaders to move the needle on growth,” said Revival Chairman and Managing Director Rick Anderson. “Our markets reward growth but . . .
Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Monthly and annual subs available.